Abstract

Thymosin beta-4 (Tβ4) is a ubiquitous protein with many properties relating to cell proliferation and differentiation that promotes wound healing and modulates inflammatory mediators. We studied the effects of chronic administration of Tβ4 on the skeletal and cardiac muscle of dystrophin deficient mdx mice, the mouse model of Duchenne muscular dystrophy. Female wild type (C57BL10/ScSnJ) and mdx mice, 8–10 weeks old, were treated with 150 µg of Tβ4 twice a week for 6 months. To promote muscle pathology, mice were exercised for 30 minutes twice a week. Skeletal and cardiac muscle function were assessed via grip strength and high frequency echocardiography. Localization of Tβ4 and amount of fibrosis were quantified using immunohistochemistry and Gomori's tri-chrome staining, respectively. Mdx mice treated with Tβ4 showed a significant increase in skeletal muscle regenerating fibers compared to untreated mdx mice. Tβ4 stained exclusively in the regenerating fibers of mdx mice. Although untreated mdx mice had significantly decreased skeletal muscle strength compared to untreated wild type, there were no significant improvements in mdx mice after treatment. Systolic cardiac function, measured as percent shortening fraction, was decreased in untreated mdx mice compared to untreated wild type and there was no significant difference after treatment in mdx mice. Skeletal and cardiac muscle fibrosis were also significantly increased in untreated mdx mice compared to wild type, but there was no significant improvement in treated mdx mice. In exercised dystrophin deficient mice, chronic administration of Tβ4 increased the number of regenerating fibers in skeletal muscle and could have a potential role in treatment of skeletal muscle disease in Duchenne muscular dystrophy.

Highlights

  • Duchenne muscular dystrophy (DMD) is an inherited X-linked disorder with an incidence of 1 in 3,500 male births that is due to the absence of dystrophin, a large protein linking the intracellular cytoskeleton to the extracellular matrix.[1]

  • Comparisons were made using Poisson regression or using negative binomial regression where the Poisson model did not fit the data due to over dispersion. Both wild type and mdx mice were treated with Thymosin beta-4 (Tb4) for 6 months and the behavioral data was collected at baseline (3 months of age), mid trial (5–6 months of age), and end of the trial (9 months of age)

  • We found no significant improvement in treated mdx skeletal or cardiac muscle function compared to untreated mdx mice

Read more

Summary

Introduction

Duchenne muscular dystrophy (DMD) is an inherited X-linked disorder with an incidence of 1 in 3,500 male births that is due to the absence of dystrophin, a large protein linking the intracellular cytoskeleton to the extracellular matrix.[1]. Commensurate with the pathology, the physical symptoms of the mdx mouse tend to be relatively mild, with muscle weakness more obvious after exercise or lengthening contractions.[4,5,6] Mdx mice develop decreased cardiac systolic function slowly over time. This decreased function can be measured at significant levels by non-invasive echocardiography around nine months of age.[7,8]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call